Top Markets
Coin of the day
Lipum AB (publ) Lipum AB (publ)

Lipum AB (publ)

LIPUM
Rank in Stocks #27266
Lipum AB (publ) is a biopharmaceutical firm based in Sweden, focused on... Lipum AB (publ) is a biopharmaceutical firm based in Sweden, focused on pioneering the discovery and development of therapeutic solutions for long-term inflammatory conditions. The company's primary therapeutic asset, SOL-116, is a humanized antibody currently in the late preclinical stage, designed to treat pediatric rheumatism and adult rheumatoid arthritis. To facilitate the advancement of SOL-116 into clinical trials, Lipum has established a collaboration with Pelago Bioscience AB to meticulously monitor drug targets. Founded in 2010, the company's operations are headquartered in UmeΓ₯, Sweden.
Share Price
$1.60
Last synced: 2026-03-18
Market Cap
$34.00M
Change (1 day)
0.70%
Change (1 year)
2.50%
Country
SE
Trade Lipum AB (publ) (LIPUM)

Category

P/B ratio for Lipum AB (publ) (LIPUM)
P/B ratio as of 2026 TTM: 0
According to Lipum AB (publ) latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Lipum AB (publ) from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.3419 -
US
3.7087 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH